Related Experiment Videos
Double-valve Libman-Sacks endocarditis: an entity that demands special consideration
Georgios P Georghiou1, Yaron Shapira, Tamara Drozd
1Department of Cardiothoracic Surgery, Rabin Medical Center, Beilinson Campus, Petach Tikva, Israel.
The Journal of Heart Valve Disease
|December 9, 2003
Summary
Systemic lupus erythematosus (SLE) can cause severe heart valve damage, requiring valve replacement. Mechanical valves are recommended for SLE patients undergoing valve surgery due to better long-term outcomes.
Area of Science:
- Cardiology
- Rheumatology
- Immunology
Background:
- Systemic lupus erythematosus (SLE) frequently manifests with cardiac involvement, particularly affecting the heart valves.
- Libman-Sacks endocarditis is a rare but serious complication of SLE, potentially leading to significant valvular dysfunction.
Observation:
- A case of a young woman with SLE presenting with moderate aortic and moderate to severe mitral regurgitation due to Libman-Sacks endocarditis is described.
- The patient experienced intractable heart failure, necessitating surgical intervention.
Findings:
- Aortic and mitral valve replacement with mechanical prostheses was performed successfully.
- Literature review revealed only nine prior reports of double-valve replacement in SLE patients.
- Valvular disease in SLE appears to progress independently of other disease features and carries high morbidity and mortality.
Implications:
- Corticosteroid therapy may help slow the progression of valvular regurgitation in SLE patients.
- Mechanical valve replacement may offer superior outcomes compared to bioprostheses in SLE patients requiring surgical intervention.
- Early recognition and management of valvular heart disease in SLE are crucial for improving patient prognosis.